http://ljpc.com/la-jolla-pharmaceutical-company-reports-positive-top-line-results-from-phase-2-clinical-trial-of-gcs-100-in-chronic-kidney-disease/
This study was for Chronic Kidney disease, but drug should confer similar results for liver. It is Galectin 3 inhibitor
Results being released right now, company presenting at Roth conference